Видео с ютуба Curevac

CureVac Tübingen - A great place to work

Durmitor National Park: Hiking to the Curevac Viewpoint

Why is Germany's CureVac vaccine just 48% effective? | Covid-19 Special

CureVac: About mRNA technology

Episode 1 | Leaving Ego Aside – Inside the CureVac–BioNTech Deal

A Tale of Two mRNA-based Vaccines: BioNTech vs. CureVac

BioNTech kauft CureVac – was Anleger jetzt wissen müssen!

Spotlight on CureVac – the RNA people

About CureVac - Get to know the RNA people

CureVac Bioprocessing Equipment Auction – Dec 10-11, 2024

CureVac Headquarters in Tübingen, Germany

CureVac CFO Sees ‘No Strings Attached’ to German Investment

CureVac strikes COVID vaccine alliance with Bayer

CureVac hopes to utilize innovations in mRNA to transform the medicines of today

CureVac fails in pivotal COVID-19 vaccine trial

Labiotech Tour South Germany 2014: CureVac with CEO Ingmar Hoerr

CureVac is focusing on mRNA cancer vaccines, CFO says

47% efficacy: Did Germany's CureVac vaccine ultimately fail? | DW News

CureVac CEO on the company's IPO and Covid-19 vaccine research